Stroke Trial, Recruiting NCT06612723 Sponsor: Indiana University Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06612723
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had a stroke more than 6 months ago that left them with weakness or movement problems on one side of the body (people who are more than 4 months post-stroke may be able to consent early, but final acceptance into the trial will not happen until after the 6-month mark)
  • People aged 18 to 85 years old
  • People who weigh less than 350 pounds
  • People who are able to follow a 3-step instruction
  • People who are able to walk at their own chosen pace — between a very slow and a moderate speed — without someone physically supporting them, though a brace below the knee and/or a walking aid may be used if needed
  • People whose leg movement after stroke falls below a certain level on a standard medical assessment scale (confirm with trial site)
  • People who have received medical clearance to take part in the study

Who may not be able to join:

  • People who have a balance and coordination condition affecting the part of the brain called the cerebellum
  • People with uncontrolled heart, lung, or metabolic conditions that limit exercise; active bone growth in abnormal places in the body; a history of repeated leg fractures; or a prior orthopaedic or nerve/brain injury that, in the lead researcher's judgement, could affect safety, ability to complete the study, or the study's goals
  • People who are currently receiving physical therapy as part of another program
  • People who have had more than 50 units of Botox injected into the lower limb — or, for people who wear an ankle-foot brace, more than 50 units injected into the lower limb above the knee — within the past three months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Thomas G Hornby, PhD, Indiana University

Phone: 317-329-2353

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
16 September 2024
Est. completion
1 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

6-minute walk test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov